Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.

P. Escobar,M. Markman,P. Rose,K. Zanotti,K. Webster,J. Belinson
DOI: https://doi.org/10.1016/J.YGYNO.2003.10.003
IF: 5.304
Gynecologic Oncology
Abstract:
What problem does this paper attempt to address?